Search Results 31-40 of 8485 for TNF
"For the last 25 years, tumor necrosis factor has been an important therapeutic target to treat autoimmune disease and tissue inflammation," says Mayo Clinic ...
Focus areas · Epigenetics and PKD . · TNF-alpha and inflammatory signaling in PKD . · Understanding the mechanisms of cilium biogenesis. · Gene therapy in ADPKD .
... TNF receptor 1 or Fas, greatly accelerated apoptosis, which was detectable within 30 minutes and was associated with accelerated activation of caspase-2, -8 ...
The lab is examining the hypothesis that ductular reactive cells induce macrophage TNF-related apoptosis-inducing ligand (TRAIL) expression as a counter- ...
The Food and Drug Administration approved the use of anti-tumor necrosis factor and anti-integrin agents for the treatment of ulcerative colitis in 2005 ...
Hypothesis: Baseline cytokine (IL-1β, IL-6, IL-4, IL-10, IFN-g and TNF-a) and the immune cellular repertoire (helper/CD4+, cytotoxic/CD8+, T-regulatory ...
... TNF-inhibitors. Correlate local levels of antigen with systemic levels measured in serum using matched patient tissue and blood sample, and correlate local ...
The NF-kappa B activation is also responsible for tumor necrosis factor-alpha (TNF-alpha) and tumor necrosis factor (TNF)-related apoptosis-inducing ligand ( ...
... tumor necrosis factor alpha (TNFa) and interleukin-2 (IL-2). These cytokines result in immunological danger signaling and multiple appealing T-cell effects ...
New medications. The immunology of IBD is very complex, and drug targeting is complex. Within the United States, four anti-TNF agents are currently approved for ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.